BECN1 and ovarian cancer: We hypothesized that DIRAS3 first binds BECN1 through its switch II region, and that inhibiting this interaction with a DIRAS3-derived peptide capable of binding Beclin1, would decrease autophagy and possibly inhibit dormant ovarian cancer cells.